<DOC>
	<DOCNO>NCT00048022</DOCNO>
	<brief_summary>The primary objective study evaluate anti-inflammatory action safety Ro 27-2441 ( study drug ) asthmatic patient currently take inhaled corticosteroid . The research conduct 40 clinical research sit US . Study participant number visit research site 4-month period .</brief_summary>
	<brief_title>Inhaled Corticosteroid Replacement Study - Efficacy Safety Ro 27-2441 ( Test Drug ) Moderate Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Persistent asthma 1 year Currently receive treatment stable dose inhale corticosteroid 3 month In good health demonstrate medical history physical exam Negative urine pregnancy test Commitment use two form effective contraception simultaneously throughout study duration 1 month discontinue therapy Hospitalization treatment asthma and/or treatment oral/injectable corticosteroid within 3 month start study Undergoing allergy shot unless stable maintenance dose 3 month start study History chronic pulmonary disease asthma Treatment condition asthma oral corticosteroid within 1 month start study Current tobacco usage Smoking history great 10 packyear history cigarette smoking ( number pack smoke per day time number year smoke ) History evidence drug alcohol abuse Diagnosis evidence infectious illness within one month Visit 1 Clinically significant disease assess study doctor Participation another clinical study experimental drug within one month start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>